Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Anghami Inc. ANGH | 3.68 3.39 | +15.72% -7.88% Post |
CF Industries Holdings, Inc. CF | 126.92 121.38 | +5.61% -4.36% Post |
Equinor ASA Sponsored ADR EQNR | 39.95 39.56 | +1.47% -0.99% Post |
Golar LNG Limited GLNG | 54.51 53.47 | +3.24% -1.91% Post |
Kosmos Energy Ltd. KOS | 2.72 2.67 | +1.12% -1.83% Post |
U.S. stock futures were higher this morning, with the Dow futures gaining around 1,000 points on Monday.
Shares of Valneva SE (NASDAQ:VALN) fell sharply in pre-market trading.
Pfizer (NYSE:PFE) and Valneva disclosed topline results from Phase 3 VALOR clinical trial of investigational 6-Valent OspA-based Lyme disease vaccine candidate PF-0730740.
Valneva shares dipped 14% to $8.88 in pre-market trading.
Here are some other stocks moving lower in pre-market trading.
- LiveWire Group Inc (NASDAQ:LVWR) shares dipped 14.6% to $1.04 in pre-market trading after dipping 10% on Friday.
- Anghami Inc (NASDAQ:ANGH) declined 14.3% to $2.40 in pre-market trading after dipping 12% on Friday.
- Golar LNG Ltd (NASDAQ:GLNG) fell 11% to $46.90 in pre-market trading.
- Kosmos Energy Ltd (NYSE:KOS) fell 10.2% to $2.55 in pre-market trading.
- Swarmer Inc (NASDAQ:SWMR) declined 9.3% to $33.30 in pre-market trading.
- Equinor ASA (NYSE:EQNR) fell 8.2% to $38.21 in pre-market trading.
- CF Industries Holdings, Inc. (NYSE:CF) fell 7.1% to $116.00 in pre-market trading.
- Venture Global Inc (NYSE:VG) fell 7% to $14.70 in pre-market trading. Venture Global and Vitol reported a new LNG purchase agreement.
- SM Energy Co (NYSE:SM) fell 5.1% to $28.50 in pre-market trading.
- PepGen Inc (NASDAQ:PEPG) fell 5.1% to $4.46 in pre-market trading. PepGen recently reported fourth-quarter financial results. The FDA placed a partial hold on the company’s FREEDOM2-DM1 Phase 2 multiple ascending dose, randomized, placebo-controlled clinical trial of PGN-EDODM1 in patients with myotonic dystrophy type 1.
Photo via Shutterstock